What do all of the above
items have in common?
· They
are all available on the internet;
· Acquiring them is a violation of
various state and federal laws;
· All but counterfeit prescription
drugs can be obtained either free or for much less than
the price of the real items. (At most internet
pharmacies, the price you pay for the counterfeit
prescription drugs is not discounted from the price of
legitimate prescription drugs but, if they sell to
the public without requiring a prescription, is
often much higher.)
WHAT ARE
COUNTERFEIT DRUGS?
Counterfeit prescription drugs usually
fall into one of the following groups:
· Fake prescription
drugs (e.g. sugar pills labeled as a prescription drug)
· Falsely labeled prescription
drugs:
o A 20
milligram prescription drug that is labeled as an 80
milligram one;
o A expired
prescription drug that is given a new expiration date
(like rolling back the mileage on a car);
o One
prescription drug that is labeled as a different
drug;
· Contaminated prescription drugs
made in illicit labs (animal feces has been found in the
drug powder stored in some of the labs; in other labs,
ingredients that were required to be refrigerated were
not and they became contaminated.);
· Prescription drugs made in part
from actual ingredients and "filler" material (e.g.
adding ground-up aspirin to some of the actual
ingredients);
· Prescription drugs that contain
more of the active ingredient than they should, making
them more harmful;
· Prescription drugs mixed with
counterfeit prescription drugs;
· Prescription drugs not approved
by the FDA for use in the United States.
HOW ARE
PRESCRIPTION DRUGS DISTRIBUTED
NOW?
The U.S.
pharmaceutical industry generates $180 billion of
revenue a year. The approximately 14,000 prescription
drugs approved by the FDA for use in the United States
are manufactured by a few hundred companies.
According to the 2003 report of a special grand jury
convened by Florida to study the counterfeit drug
problem in Florida ("2003 Report"):
· Approximately 46% of all legal prescription drugs
were shipped directly to dispensers such as hospitals
and pharmacy chains;
· Approximately 49% of the legal
prescription drugs went to the three largest
wholesalers;
· The remaining 5% were shipped
to the several thousand smaller wholesalers.
Once the drugs
are shipped from the manufacturers, tracing them becomes
more difficult. The larger wholesalers will sell
to the smaller wholesalers, who then sell to each other
and sometimes to dispensers.
When
manufacturers sell prescription drugs, they deliver a
piece of paper documenting that the prescription drugs
are legitimate. This paper is called a
pedigree. In most states, wholesalers of the drugs
are not required to show proof that the prescription
drugs have the proper pedigree-the proof that they came
from the manufacturer. In addition, even if
required to provide a pedigree, many wholesalers don't
verify a pedigree if another wholesaler offers them a
"good deal."
This lack of
requirement of a legitimate pedigree is the reason why
more and more counterfeit drugs are getting into the
hands of the public-sometimes from legitimate pharmacies
or other trusted dispensers.
WHY SELL
COUNTERFEIT DRUGS?
There is a one
word answer-greed. Criminals who seek to profit at
the expense of others are rapidly moving into the
counterfeit prescription drug business. In a study
entitled "The Good, the Bad and the Ugly" written
by Kevin Outterson and Ryan Smith and published in
the Albany Journal of Science & Technology (2006),
the authors explain, "The marginal cost of producing
most name-brand drugs is a small fraction of the
commercial price. An annual supply of a well-known
antiretroviral triple combination drug regime in the
United States costs over $11,000 at retail. Unlicensed
generic companies sell the same drugs in sub-Saharan
Africa for $244." In other words, these drugs are sold
in the United States at 45 times what it cost to produce
them.
The authors
point out that generic ciprofloxacin, the drug used to
treat anthrax, is sold in other parts of the world for
0.4% of the price in the United States, a ratio of
246:1. (The authors say that it is estimated that
cocaine has a 25:1 ratio.) They also explain that these
ratios are assuming that the criminal is using the
actual pharmaceutical ingredients. Similar to
dealers in cocaine and heroin who want to deliver a good
product to ensure that their customers will keep
returning, many criminal manufacturers of certain drugs
will use the proper ingredients.
However, many
other criminals have decided that they just want to make
a profit and will use only some or maybe none of the
actual ingredients-to cut costs and make more
money.
The 2003
Report then states, "In Florida alone there are 422
in-state and 977 out of state wholesalers licensed to
sell pharmaceutical products within this state. To put
this number in context, there are approximately 3,400
walk-in and 1,000 institutional pharmacies in Florida,
or approximately one wholesaler for every three
pharmacies."
Then in
language rarely seen in public documents, the 2003
Report continues, "Many of the wholesalers in Florida's
market are unqualified, inexperienced, irresponsible and
incompetent to properly handle, store or deal in
pharmaceuticals. Some even have criminal records, though
how many is impossible to know since Florida only does
minimal background checks before issuing wholesale
permits. Any drugs that come into the possession of
these wholesalers, whether acquired legally or
illegally, are likely to become tainted due to improper
handling and storage.
An alarming
percentage of the drugs flowing through the wholesale
market have been illegally acquired. That is, they have
been stolen from shipments, pharmacies, clinics, and
hospitals; purchased on the black market from recipients
and health care professionals who are defrauding
insurance companies or Medicaid with bogus
prescriptions; or illegally imported from overseas. This
activity is commonly referred to as drug
diversion."
COUNTERFEIT
DRUGS-HOW BIG A PROBLEM?
Counterfeit
prescription drug sales are expanding on the
internet. The World Health Organization
estimates:
· 50% of
the prescription drugs purchased from internet
pharmacies without physical addresses are
counterfeit;
· Global counterfeit drug sales
have increased more than 90% since 2005;
· Global counterfeit drug sales
will exceed $75 billion by 2010.
Of course,
some of these counterfeit drugs are also going to get
into the hands of addicts. Some of the counterfeit
prescription drugs will be harmless-they just won't give
the users a "high". But others may not be so
harmless.
In 2003 the FDA issued an alert that
200,000 bottles of counterfeit Lipitor had gotten into
the United States. Lipitor is the type of drug
that counterfeiters like for these reasons:
· Lipitor
sales are almost $3 billion per year.
· Unless it has some toxic
ingredients, it will not show up as being counterfeit
for some time-until the person realizes that their
cholesterol has shot up higher.
· If the person is ordering the
prescription drug over the internet, presumably without
a prescription, then they are unlikely to report their
own crime to the police.
· Law enforcement agencies are
concentrating on stopping the illegal drug trade and few
law enforcement agencies are directing attention to
stopping illegal prescription drug traffic.
THE FDA'S CRIMINAL
NEGLIGENCE
Counterfeit
drugs are recognized as a huge problem in other parts of
the world--an estimated 100,000 people a year die in
China from taking counterfeit prescription drugs.
Recently, counterfeit prescription drugs have taken the
lives of 19 Americans and caused severe injury to
hundreds more.
Many people getting dialysis and heart
surgery take large doses of heparin, a generic blood
thinner. The heparin sold by Baxter International
contained contaminated ingredients that were purchased
from a plant in China.
It turns out that the FDA did not, as
they were supposed to, investigate the Chinese
plant. In fact, Rep. John Dingell, a
Michigan Democrat who chairs the House Committee on
Energy and Commerce, said, "Only 13 inspections were
conducted in China in 2007. At this rate, it would take
the FDA 55 years just to clear this backlog."
Representative Tom Bliley said, "The
FDA's regulatory system used to protect Americans from
counterfeit or substandard drug ingredients has
significant holes." Bliley said the FDA allows the
import of drugs based "merely on the representations of
an international broker, who could in fact be the
counterfeiter."
"The FDA
admits it has information on only 18 percent of the
foreign drug manufacturers shipping to the U.S," Bliley
added. He reports that since 1997, some 4,600 foreign
drug makers have shipped medication into the U.S.
without getting inspected.
According to an article entitled, "FDA
Scrutiny Scant In India, China as Drugs Pour Into U.S.,
Broad Overseas Checks Called Too Costly", by Marc
Kaufman that appeared on June 17, 2007 in the Washington
Post, "Companies based in India were bit players in the
American drug market 10 years ago, selling just eight
generic drugs here. Today, almost 350 varieties and
strengths of antidepressants, heart medicines,
antibiotics and other drugs purchased by American
consumers are made by Indian manufacturers.
Analysts estimate that as much as 20
percent of finished generic and over-the-counter drugs,
and more than 40 percent of the active ingredients for
pills made here, come from India and China. Within 15
years, they predict, as much as 80 percent of the key
ingredients will come from those countries -- which are
quickly becoming attractive to brand-name drugmakers,
too."
The article also states, "Over the past
seven years, amid explosive growth in imports from India
and China, the FDA conducted only about 200 inspections
of plants in those countries, and a few were the kind
that U.S. firms face regularly to ensure that the drugs
they make are of high quality.
The agency, which is responsible for
ensuring the safety of drugs for Americans wherever they
are manufactured, made 1,222 of these quality-assurance
inspections in the United States last year. In India,
which has more plants making drugs and drug ingredients
for American consumers than any other foreign nation, it
conducted a handful."
The FDA again proves that they don't
see their job as helping the consumer but the drug
companies.
TWO MORE DRUG
COMPANIES FORCED TO PAY
The terms of
the settlement were supposed to be confidential, but
$48.55 million is being paid by Eli Lilly and $23.55
million by Bristol Myers Squibb to settle a suit filed
by 500 cancer patients. Kansas City pharmacist
Robert Courtney admitted to diluting the two
chemotherapy drugs Gemzar and Taxol so that he could
sell more of the drugs to his patients. The suit
alleged that Lilly and Squibb buy and analyze data that
tracks pharmaceutical sales and knew that Courtney was
reporting sales of many more of their drugs than he was
buying. The suit also alleged that rather than
notify the doctors prescribing the medication or the
authorities, both companies decided to keep quiet and
500 hundred innocent people suffered. Squibb and
Lilly denied the allegations but settled the case with
the agreement that all the court records be
sealed.
CONCLUSION
A man was
arrested for embezzling from a group of retired
people. Many of his victims came to court to
demand more jail time for the man. After listening
to the victims for an hour, the judge turned to the man
and asked, "You have heard from all these nice
people. How could you take money from people who
trusted you?" The man said to the judge, "Your
Honor, those are the only kind of people from whom you
can take money."
The purveyors
of counterfeit drugs, the FDA and the drug companies
will only be able to take our money and our health from
us if we continue to trust them.
At Novus
Medical Detox Center, we will do our part to save people
from their misguided trust in prescription drugs, the
FDA and the drug companies.
NOTE: This email is provided for general
educational purposes only and is not intended to
constitute (i) medical advice or counseling, (ii)
the practice of medicine including psychiatry,
psychology, psychotherapy or the provision of health
care diagnosis or treatment, (iii) the creation of a
physician patient or clinical relationship, or (iv) an
endorsement, recommendation or sponsorship of any third
party product or service by the sender or the sender's
affiliates, agents, employees, consultants or service
providers. If you have or suspect that you have a
medical problem, contact your health
care provider
promptly.